Celebration, Florida November 12th, 2007. Prostate cancer strikes one in six American men. The diagnosis can be a terrifying, life-altering experience, requiring very difficult decisions about what kind of treatment is best. Nearly all options carry certain risks involving longevity, and lifestyle impairments such as impotence and incontinence. However, there is a new procedure that is changing these risks and giving patients with prostate cancer their lives back.

HIFU treatment is a non invasive procedure that can destroy prostate tissue while preserving the nerve bundles around the prostate. The HIFU procedure, which is short for High Intensity Focused Ultrasound, is a state-of-the-art technique that utilizes the power of focused ultrasound to destroy deep-seated prostate cancer tissue with pinpoint accuracy. The control and precision of HIFU treatment reduces the risk of common side effects such as impotence and incontinence. HIFU treatment is a 1-3 hour, one-time procedure performed on an out-patient basis under spinal or epidural anesthesia, in most cases. The patient experiences no pain and no bloodloss during the procedure. The prostate specialist uses continuously updated real-time images of the prostate to map out and execute the entire process. These images show the progress and permit the doctor to instantly and continuously customize the procedure for maximum safety and effectiveness. Unlike radiation, HIFU treatment is non-ionizing so it can be repeated if necessary without damaging healthy tissue. This means that the HIFU treatment can also be used as a salvage technique if other prostate cancer treatments fail.

A breakthrough procedure like this is to be celebrated! And this news is to be shared. Dr. Lotenfoe is more than happy to answer any questions you have on the revolutionary procedure that is changing the face of cancer treatment. Call today to find out more about HIFU treatment! 1-877-458-8443 (877-I-LUV-HIFU) or visit www.hifucare.com

The Sonablate 500 is being studied in clinical trials for use in the treatment of prostate cancer in the United States and is not approved for use by the U.S. Food and Drug Administration. HIFU treatment with the Sonablate 500 is authorized for use for the treatment of prostate cancer in Canada, Argentina and the Dominican Republic. It is also available in the Bahamas and Mexico.

CONTACT PERSON Jeff Walker
COMPANY NAME Dr. Richard Lotenfoe, M.D.
TELEPHONE NUMBER 1-877-I- LUV-HIFU
FAX NUMBER 407-454-7888
EMAIL ADDRESS info@drlotenfoe.com
WESITE ADDRESS www.hifucare.com